MICRORHEOLOGY OF ERYTHROCYTES IN ARTERIAL HYPERTENSION AND DYSLIPIDEMIA WITH A COMPLEX HYPOLIPIDEMIC TREATMENT

Aim. To evaluate the applicability of a complex of non-medication treatment and simvastatin in hypertension and dyslipidemia management, from perspective of disordered rheological properties of erythrocytes.Material and methods. Totally, 55 hypertensive patients included, with 1-2 grade of hypertens...

Full description

Bibliographic Details
Main Author: I. N. Medvedev
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC  2017-05-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/689
id doaj-25924199885b4ff7b4417859afde217b
record_format Article
spelling doaj-25924199885b4ff7b4417859afde217b2021-07-28T14:02:29Zrus«FIRMA «SILICEA» LLC Российский кардиологический журнал1560-40712618-76202017-05-0104131810.15829/1560-4071-2017-4-13-18718MICRORHEOLOGY OF ERYTHROCYTES IN ARTERIAL HYPERTENSION AND DYSLIPIDEMIA WITH A COMPLEX HYPOLIPIDEMIC TREATMENTI. N. Medvedev0Kursk Institute of Social Education (brunch) of Russian State Social UniversityAim. To evaluate the applicability of a complex of non-medication treatment and simvastatin in hypertension and dyslipidemia management, from perspective of disordered rheological properties of erythrocytes.Material and methods. Totally, 55 hypertensive patients included, with 1-2 grade of hypertension and IIb type dyslipidemia, risk 4, middle age. Controls were 26 healthy persons of the same age. The biochemical, hematological and statistical methods were applied.Results. Simultaneous application of non-drug treatment and simvastatin in arterial hypertension with dyslipidemia does make optimal the lipid profile of plasma in 12 weeks, and lipid content of erythrocytes, lipids peroxidation of the liquid blood and red blood cells — in 6 weeks. Prescription of non-drug management and simvastatin to the studied patients does normalize their cytoarchitectonics and spontaneous erythrocyte aggregation in 6 weeks of treatment, having retained the results for at least the following 98 weeks of treatment.Conclusion. Complex application of non-medication treatment and simvastatin does normalize erythrocyte microrheologic properties for 6 weeks in hypertension patients with dyslipidemia.https://russjcardiol.elpub.ru/jour/article/view/689arterial hypertensiondyslipidemiaaggregationcytoarchitectonicserythrocytessimvastatinhypolipidemic dietexercises
collection DOAJ
language Russian
format Article
sources DOAJ
author I. N. Medvedev
spellingShingle I. N. Medvedev
MICRORHEOLOGY OF ERYTHROCYTES IN ARTERIAL HYPERTENSION AND DYSLIPIDEMIA WITH A COMPLEX HYPOLIPIDEMIC TREATMENT
Российский кардиологический журнал
arterial hypertension
dyslipidemia
aggregation
cytoarchitectonics
erythrocytes
simvastatin
hypolipidemic diet
exercises
author_facet I. N. Medvedev
author_sort I. N. Medvedev
title MICRORHEOLOGY OF ERYTHROCYTES IN ARTERIAL HYPERTENSION AND DYSLIPIDEMIA WITH A COMPLEX HYPOLIPIDEMIC TREATMENT
title_short MICRORHEOLOGY OF ERYTHROCYTES IN ARTERIAL HYPERTENSION AND DYSLIPIDEMIA WITH A COMPLEX HYPOLIPIDEMIC TREATMENT
title_full MICRORHEOLOGY OF ERYTHROCYTES IN ARTERIAL HYPERTENSION AND DYSLIPIDEMIA WITH A COMPLEX HYPOLIPIDEMIC TREATMENT
title_fullStr MICRORHEOLOGY OF ERYTHROCYTES IN ARTERIAL HYPERTENSION AND DYSLIPIDEMIA WITH A COMPLEX HYPOLIPIDEMIC TREATMENT
title_full_unstemmed MICRORHEOLOGY OF ERYTHROCYTES IN ARTERIAL HYPERTENSION AND DYSLIPIDEMIA WITH A COMPLEX HYPOLIPIDEMIC TREATMENT
title_sort microrheology of erythrocytes in arterial hypertension and dyslipidemia with a complex hypolipidemic treatment
publisher «FIRMA «SILICEA» LLC 
series Российский кардиологический журнал
issn 1560-4071
2618-7620
publishDate 2017-05-01
description Aim. To evaluate the applicability of a complex of non-medication treatment and simvastatin in hypertension and dyslipidemia management, from perspective of disordered rheological properties of erythrocytes.Material and methods. Totally, 55 hypertensive patients included, with 1-2 grade of hypertension and IIb type dyslipidemia, risk 4, middle age. Controls were 26 healthy persons of the same age. The biochemical, hematological and statistical methods were applied.Results. Simultaneous application of non-drug treatment and simvastatin in arterial hypertension with dyslipidemia does make optimal the lipid profile of plasma in 12 weeks, and lipid content of erythrocytes, lipids peroxidation of the liquid blood and red blood cells — in 6 weeks. Prescription of non-drug management and simvastatin to the studied patients does normalize their cytoarchitectonics and spontaneous erythrocyte aggregation in 6 weeks of treatment, having retained the results for at least the following 98 weeks of treatment.Conclusion. Complex application of non-medication treatment and simvastatin does normalize erythrocyte microrheologic properties for 6 weeks in hypertension patients with dyslipidemia.
topic arterial hypertension
dyslipidemia
aggregation
cytoarchitectonics
erythrocytes
simvastatin
hypolipidemic diet
exercises
url https://russjcardiol.elpub.ru/jour/article/view/689
work_keys_str_mv AT inmedvedev microrheologyoferythrocytesinarterialhypertensionanddyslipidemiawithacomplexhypolipidemictreatment
_version_ 1721269094442860544